Creonate Manufacturing sets up to provide diagnostic manufacturing in a world class environment

Creonate Manufacturing sets up to provide diagnostic manufacturing in a world class environment

About Creonate Manufacturing Ltd.

Born in 2022 through the opportunity to secure the future of a completely unique manufacturing initiative created by Global Access Diagnostics during the pandemic of 2020 and 2021.

Established as a social enterprise, dedicated to securing and prioritising the provision of diagnostic products and components for developing countries to ensure that local manufacturing initiatives can operate unimpeded by mature market greed, while offering surge capacity backup, these core principles remain steadfastly the foundations of Creonate.

Leaders in diagnostic manufacturing in a world class environment
From concept to commercialisation, Creonate’s multifaceted team and flexible quality system combine to rapidly accommodate or develop SOPs and QC procedures. Established infrastructure allows for rapid product delivery and includes an expansive network of suppliers, component manufacturers and distributors. Creonate’s manufacturing processes operate to ISO 13485:2016 and MDSAP standards.

With a 7,000 sq ft, fully HVAC-controlled warehouse facilities, Creonate can store your physical inventory for sale or distribution. With a secure site and excellent connections to the M1, they offer an ideal storage facility conveniently placed for HGV access.

Biotangents launch mastitis diagnostic product

Biotangents launched the AmpliSpec LAB Mastitis device in an event at the Moredun Research Institute, close to its headquarters at the Pentlands Science Park near Edinburgh. The disease is estimated to cost the global dairy industry around £25 billion a year.

Read More »